Kevin Heal
Stock Analyst at Argus Research
(3.93)
# 626
Out of 4,667 analysts
46
Total ratings
60.71%
Success rate
8.79%
Average return
Main Sectors:
Stocks Rated by Kevin Heal
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
NDAQ Nasdaq | Maintains: Buy | $76 → $82 | $80.08 | +2.40% | 4 | Nov 5, 2024 | |
RF Regions Financial | Upgrades: Buy | $26 | $26.55 | -2.07% | 2 | Oct 24, 2024 | |
ZION Zions Bancorporation, National Association | Downgrades: Hold | n/a | $58.66 | - | 2 | Jul 25, 2024 | |
HBAN Huntington Bancshares | Maintains: Buy | $15 → $16 | $17.47 | -8.41% | 3 | Jul 22, 2024 | |
MET MetLife | Maintains: Buy | $77 → $80 | $83.00 | -3.61% | 2 | May 22, 2024 | |
ICE Intercontinental Exchange | Reiterates: Buy | $153 | $156.36 | -2.15% | 5 | May 21, 2024 | |
AMP Ameriprise Financial | Maintains: Buy | $440 → $460 | $561.40 | -18.06% | 1 | May 6, 2024 | |
CFG Citizens Financial Group | Maintains: Buy | $36 → $39 | $46.12 | -15.44% | 5 | Apr 24, 2024 | |
CME CME Group | Maintains: Buy | $225 → $245 | $228.00 | +7.46% | 2 | Mar 6, 2024 | |
RITM Rithm Capital | Maintains: Buy | $11 → $12 | $10.68 | +12.36% | 1 | Mar 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $67.88 | - | 3 | Jan 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $208.73 | - | 5 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $13.68 | - | 3 | May 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.47 | - | 1 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.65 | - | 1 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.08 | - | 2 | Jun 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $199.35 | - | 2 | May 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $185 | $283.58 | -34.76% | 2 | Jul 30, 2021 |
Nasdaq
Nov 5, 2024
Maintains: Buy
Price Target: $76 → $82
Current: $80.08
Upside: +2.40%
Regions Financial
Oct 24, 2024
Upgrades: Buy
Price Target: $26
Current: $26.55
Upside: -2.07%
Zions Bancorporation, National Association
Jul 25, 2024
Downgrades: Hold
Price Target: n/a
Current: $58.66
Upside: -
Huntington Bancshares
Jul 22, 2024
Maintains: Buy
Price Target: $15 → $16
Current: $17.47
Upside: -8.41%
MetLife
May 22, 2024
Maintains: Buy
Price Target: $77 → $80
Current: $83.00
Upside: -3.61%
Intercontinental Exchange
May 21, 2024
Reiterates: Buy
Price Target: $153
Current: $156.36
Upside: -2.15%
Ameriprise Financial
May 6, 2024
Maintains: Buy
Price Target: $440 → $460
Current: $561.40
Upside: -18.06%
Citizens Financial Group
Apr 24, 2024
Maintains: Buy
Price Target: $36 → $39
Current: $46.12
Upside: -15.44%
CME Group
Mar 6, 2024
Maintains: Buy
Price Target: $225 → $245
Current: $228.00
Upside: +7.46%
Rithm Capital
Mar 5, 2024
Maintains: Buy
Price Target: $11 → $12
Current: $10.68
Upside: +12.36%
Jan 29, 2024
Downgrades: Hold
Price Target: n/a
Current: $67.88
Upside: -
Nov 16, 2023
Downgrades: Hold
Price Target: n/a
Current: $208.73
Upside: -
May 22, 2023
Upgrades: Hold
Price Target: n/a
Current: $13.68
Upside: -
Feb 21, 2023
Downgrades: Hold
Price Target: n/a
Current: $19.47
Upside: -
Feb 6, 2023
Downgrades: Hold
Price Target: n/a
Current: $9.65
Upside: -
Jun 2, 2022
Downgrades: Hold
Price Target: n/a
Current: $6.08
Upside: -
May 20, 2022
Downgrades: Hold
Price Target: n/a
Current: $199.35
Upside: -
Jul 30, 2021
Upgrades: Buy
Price Target: $185
Current: $283.58
Upside: -34.76%